Inimmune Collaborates with Boston Children’s Hospital to Develop Novel Adjuvants
MISSOULA, Montana, October, 24, 2023 – Inimmune Corporation, a clinical-stage biotechnology company focused on creating and developing innovative immunotherapeutics, announced that it has entered a research collaboration with Boston Children’s Hospital (BCH) to develop novel and innovative small molecule vaccine adjuvants. An adjuvant is added to some vaccines to enhance the immune response, thereby creating a […]
